Dopamine D2/3 Receptor Occupancy Following Dose Reduction Is Predictable with Minimal Plasma Antipsychotic Concentrations: An Open-Label Clinical Trial

Shinichiro Nakajima, Hiroyuki Uchida, Robert R. Bies, Fernando Caravaggio, Takefumi Suzuki, Eric Plitman, Wanna Mar, Philip Gerretsen, Bruce G. Pollock, Benoit H. Mulsant, David C. Mamo, Ariel Graff-Guerrero

Research output: Contribution to journalArticle

17 Scopus citations

Fingerprint Dive into the research topics of 'Dopamine D<sub>2/3</sub> Receptor Occupancy Following Dose Reduction Is Predictable with Minimal Plasma Antipsychotic Concentrations: An Open-Label Clinical Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences